Researchers have completed genomic mapping of E. coli bacterial capsules to identify high-risk types that could inform vaccine development strategies. The study focuses on capsules, sugar-rich outer layers that shield bacteria from immune detection and certain therapies, as key determinants of whether E. coli strains become invasive.
The research examined the relationship between specific capsule types and bacterial virulence, aiming to understand which variants pose the greatest threat to human health. E. coli capsules serve as protective barriers that help pathogenic strains evade host immune responses and resist therapeutic interventions.